Skip to content
★ Sign in to follow
IA

ISU Abxis Co., Ltd. Stock: price and insider trades · South Korea

이수앱지스

KR·Mcap ₩160.4BHealth Care

No insider purchase over the last 90 days. The latest, by 김세민, was filed 22 Jul 2026.

ISU Abxis Co., Ltd.: what insiders have been doing

ISU Abxis Co., Ltd. is a Health Care company. Its directors and officers file their transactions with DART (FSS). From 10 November 2025 to 10 November 2026, the disclosure feed for ISU Abxis Co., Ltd. logged 5 filings by 3 insiders.

Both sides are active: 2 purchases and 1 sale, from 2 insiders and 1 insider respectively. The totals exclude 3 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Those buying include 1 senior executive.

Across the 2,630 companies tracked on its exchange, the median is 7 filings; at 5 filings, this issuer sits below that mark. Over the whole record (from 2021), the tally stands at 23 purchases and 2 sales.

The last insider purchase was made public on 22 July 2026, 111 days ago.

For comparison within the same sector, see the insider buying recorded at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Source: insider filings from DART (FSS). Past trades are no guide to future returns.

Insider Decl.
28
Thresholds
n/a
Buy Volume
n/a
23 ops. · all time
Sell Volume
n/a
2 ops. · all time

Who traded when

BuySale
김상범1 buy1 sale
김세민1 buy
노기성1 buy
이수화학1 buy
Fundamental score
Ranked 19,889 of 26,911 companies
35.3
score / 100
Value
28
Quality
43
FCF yld-0.1%
Earn yld-8.2%
EV/EBITDA·
ROE·
Gross mgn54%
Net mgn-19%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩3,935
Analyst consensus
·
Income statement
Revenue₩56.7B
Gross profit₩30.5B54% margin
EBITDA-₩378.9M-1% margin
Net income-₩10.7B-18.8% margin
Balance sheet & cash
Market cap₩160.4B
Total debt₩29.4B
Free Cash Flow-₩89.7M
Last declaration on 22 July 2026
Declarations30 total
  • Other
    Other(filed)
    0DART
  • ▲
    사실상지배주주Executives(filed)
    0DART
    708,541 sharesShareKRXDART:20260722000562
    Canonical exit: 20 Oct 2026 (T+90)
  • ▼
    회장Executives(filed)
    0DART
    1,400,000 sharesShareKRXDART:20260722000563
  • Other
    Other(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Executives
    0DART
    1,000 sharesShareKRXDART:20260108000434
    Canonical exit: 1 Apr 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    0DART
    97,000 sharesKRXDART:20250708000224
    Canonical exit: 6 Oct 2025 (T+90)
  • ▲
    Executives
    0DART
    97,000 sharesShareKRXDART:20250708000137
    Canonical exit: 1 Oct 2025 (T+90)
  • ▼
    Related company / holdingExecutives
    0DART
    87,545 sharesKRXDART:20240115000238
  • ▲
    회장Executives
    0DART
    ShareKRXDART:20231222000499
    Canonical exit: 21 Mar 2024 (T+90)
  • ▲
    Related company / holdingExecutives
    0DART
    586,193 sharesKRXDART:20231222000550
    Canonical exit: 21 Mar 2024 (T+90)
  • ▲
    Related company / holdingExecutives
    0DART
    586,193 sharesKRXDART:20231025000038
    Canonical exit: 22 Jan 2024 (T+90)
  • ▲
    회장Executives
    0DART
    ShareKRXDART:20231025000018
    Canonical exit: 22 Jan 2024 (T+90)
  • ▲
    회장Executives
    0DART
    ShareKRXDART:20230623000163
    Canonical exit: 14 Sept 2023 (T+90)
  • ▲
    Related company / holdingExecutives
    0DART
    586,193 sharesKRXDART:20230623000158
    Canonical exit: 14 Sept 2023 (T+90)
  • ▲
    Related company / holdingExecutives(filed)
    0DART
    586,193 sharesKRXDART:20220707000400
    Canonical exit: 5 Oct 2022 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    회장Executives(filed)
    0DART
    ShareKRXDART:20211006000531
    Canonical exit: 4 Jan 2022 (T+90)
  • ▲
    Related company / holdingExecutives(filed)
    0DART
    586,193 sharesKRXDART:20211006000543
    Canonical exit: 4 Jan 2022 (T+90)
  • ▲
    Related company / holdingExecutives(filed)
    0DART
    586,193 sharesKRXDART:20210629000641
    Canonical exit: 27 Sept 2021 (T+90)
  • ▲
    회장Executives(filed)
    0DART
    ShareKRXDART:20210629000642
    Canonical exit: 27 Sept 2021 (T+90)
  • ▲
    회장Executives(filed)
    0DART
    ShareKRXDART:20210608000220
    Canonical exit: 6 Sept 2021 (T+90)
  • ▲
    Related company / holdingExecutives(filed)
    0DART
    586,193 sharesKRXDART:20210608000217
    Canonical exit: 6 Sept 2021 (T+90)
  • ▲
    회장Executives(filed)
    0DART
    ShareKRXDART:20210518000456
    Canonical exit: 18 Aug 2021 (T+90)

25 of 30 declarations

About ISU Abxis Co., Ltd.

이수앱지스 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of innovative drugs and treatments.